Glasgow, United Kingdom

ESTRO 2024

Session

Monday
May 06
15:00 - 16:15
Armadillo
Difficult-to-treat and challenging head and neck cancer patients: Who they are and how to improve outcomes?
Gaber Plavc, Slovenia;
James Bates, USA
Attendees can anticipate a scientific symposium encompassing critical aspects of head and neck cancer care. Topics will include an examination of how socioeconomic factors impact treatment outcomes, along with discussions on strategies aimed at reducing the observed survival gap. Presentations will also analyze the prevalence of cisplatin ineligibility among elderly patients and the varied care patterns observed globally. Potential treatment intensification strategies, particularly in the context of HPV-negative oropharyngeal cancers, will be explored. Additionally, the session will provide insights into the radiobiological mechanisms contributing to treatment resistance in squamous cell carcinoma, with a focus on identifying potential biomarkers and personalized therapeutic approaches.
3370
Symposium
Clinical
15:00 - 15:18
Social inequality and other socioeconomic factors affecting treatment in head and neck cancer care: Can we actually do something?
Maja Halgren Olsen, Denmark
15:18 - 15:36
HPV-negative oropharynx cancer: The neglected disease
Pernille Lassen, Denmark
15:36 - 15:54
The elderly patient unfit for cisplatin: Then what?
Alexander Rühle, Germany
15:54 - 16:12
The "poor responder" after radiotherapy for SCCHN from radiobiological point of view
Ingeborg Tinhofer-Keilholz, Germany